Marcelo Sousa
Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bacterial Outer Membrane Proteins | 14 | 2025 | 62 | 5.220 |
Why?
| | Escherichia coli Proteins | 14 | 2025 | 201 | 4.950 |
Why?
| | Polymyxins | 6 | 2023 | 10 | 2.740 |
Why?
| | Escherichia coli | 11 | 2025 | 838 | 2.350 |
Why?
| | Lipid A | 3 | 2023 | 29 | 1.270 |
Why?
| | Models, Molecular | 19 | 2018 | 1603 | 1.180 |
Why?
| | Protein Conformation | 12 | 2014 | 941 | 1.090 |
Why?
| | Protein Structure, Tertiary | 12 | 2015 | 859 | 1.090 |
Why?
| | Protein Folding | 10 | 2025 | 278 | 1.010 |
Why?
| | Bacterial Proteins | 5 | 2023 | 911 | 0.960 |
Why?
| | Amino Sugars | 4 | 2023 | 6 | 0.900 |
Why?
| | Rhodothermus | 2 | 2015 | 2 | 0.840 |
Why?
| | Crystallography, X-Ray | 12 | 2014 | 485 | 0.810 |
Why?
| | NAD | 1 | 2023 | 78 | 0.780 |
Why?
| | Type III Secretion Systems | 1 | 2021 | 14 | 0.690 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2021 | 61 | 0.660 |
Why?
| | Guanylate Cyclase-Activating Proteins | 3 | 2010 | 6 | 0.610 |
Why?
| | Thermodynamics | 2 | 2021 | 424 | 0.600 |
Why?
| | Drug Resistance, Bacterial | 2 | 2014 | 192 | 0.580 |
Why?
| | Scattering, Small Angle | 2 | 2015 | 26 | 0.540 |
Why?
| | Protein Structure, Secondary | 6 | 2016 | 368 | 0.540 |
Why?
| | Aldose-Ketose Isomerases | 2 | 2013 | 6 | 0.490 |
Why?
| | Drug Resistance, Microbial | 2 | 2005 | 65 | 0.460 |
Why?
| | Carboxy-Lyases | 2 | 2005 | 9 | 0.460 |
Why?
| | Gram-Negative Bacteria | 2 | 2021 | 81 | 0.450 |
Why?
| | Molecular Chaperones | 2 | 2009 | 198 | 0.450 |
Why?
| | Calcium | 4 | 2010 | 1187 | 0.450 |
Why?
| | X-Ray Diffraction | 1 | 2015 | 104 | 0.440 |
Why?
| | Transaminases | 1 | 2014 | 23 | 0.420 |
Why?
| | Binding Sites | 7 | 2015 | 1316 | 0.420 |
Why?
| | Anti-Bacterial Agents | 3 | 2023 | 1865 | 0.410 |
Why?
| | Amino Acid Sequence | 9 | 2014 | 2158 | 0.390 |
Why?
| | Salmonella typhimurium | 1 | 2014 | 185 | 0.370 |
Why?
| | Periplasmic Proteins | 1 | 2010 | 4 | 0.340 |
Why?
| | Molecular Sequence Data | 9 | 2013 | 2929 | 0.340 |
Why?
| | Vision, Ocular | 2 | 2008 | 46 | 0.330 |
Why?
| | Uridine Diphosphate Glucuronic Acid | 3 | 2023 | 3 | 0.320 |
Why?
| | Protein Binding | 7 | 2016 | 2239 | 0.320 |
Why?
| | Pseudomonas aeruginosa | 1 | 2012 | 358 | 0.320 |
Why?
| | Periplasm | 3 | 2016 | 13 | 0.320 |
Why?
| | Substrate Specificity | 5 | 2014 | 385 | 0.320 |
Why?
| | Microscopy, Atomic Force | 3 | 2021 | 128 | 0.310 |
Why?
| | DNA-Binding Proteins | 2 | 2009 | 1478 | 0.310 |
Why?
| | Retinal Diseases | 2 | 2008 | 96 | 0.290 |
Why?
| | Kinetics | 2 | 2025 | 1652 | 0.290 |
Why?
| | Avian Proteins | 1 | 2007 | 22 | 0.270 |
Why?
| | Cell Membrane | 2 | 2023 | 724 | 0.250 |
Why?
| | Retinal Cone Photoreceptor Cells | 1 | 2006 | 21 | 0.240 |
Why?
| | Catalytic Domain | 3 | 2014 | 224 | 0.240 |
Why?
| | Uridine Diphosphate Glucose Dehydrogenase | 1 | 2005 | 1 | 0.240 |
Why?
| | Mutation | 5 | 2016 | 4013 | 0.230 |
Why?
| | Uronic Acids | 1 | 2025 | 1 | 0.230 |
Why?
| | Diphosphates | 1 | 2025 | 19 | 0.230 |
Why?
| | Ligands | 2 | 2023 | 667 | 0.220 |
Why?
| | Nucleotides | 1 | 2025 | 127 | 0.220 |
Why?
| | Phosphatidate Phosphatase | 1 | 2023 | 5 | 0.210 |
Why?
| | SEC Translocation Channels | 1 | 2023 | 10 | 0.210 |
Why?
| | Arabinose | 1 | 2023 | 4 | 0.210 |
Why?
| | Carbohydrates | 1 | 2023 | 68 | 0.200 |
Why?
| | Molecular Dynamics Simulation | 4 | 2018 | 246 | 0.200 |
Why?
| | Oxidoreductases | 1 | 2023 | 96 | 0.190 |
Why?
| | Serine Endopeptidases | 1 | 2002 | 119 | 0.180 |
Why?
| | Heat-Shock Proteins | 1 | 2002 | 142 | 0.180 |
Why?
| | Protein Domains | 3 | 2018 | 301 | 0.170 |
Why?
| | Salmonella | 1 | 2021 | 63 | 0.170 |
Why?
| | Protein Stability | 1 | 2021 | 175 | 0.170 |
Why?
| | Hydrogen Bonding | 2 | 2014 | 168 | 0.160 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2013 | 391 | 0.150 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2018 | 44 | 0.140 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 2 | 2018 | 344 | 0.140 |
Why?
| | Guanylate Cyclase | 2 | 2008 | 38 | 0.130 |
Why?
| | Cyclic GMP | 2 | 2008 | 91 | 0.130 |
Why?
| | Base Sequence | 2 | 2014 | 2180 | 0.130 |
Why?
| | Crystallization | 2 | 2008 | 146 | 0.130 |
Why?
| | Recombinant Proteins | 2 | 2014 | 1357 | 0.120 |
Why?
| | Ionic Liquids | 1 | 2015 | 7 | 0.120 |
Why?
| | Amino Acid Motifs | 2 | 2014 | 225 | 0.120 |
Why?
| | Liposomes | 1 | 2017 | 224 | 0.120 |
Why?
| | Hydroxymethyl and Formyl Transferases | 2 | 2005 | 2 | 0.120 |
Why?
| | Spectrum Analysis | 1 | 2015 | 92 | 0.120 |
Why?
| | Cations | 1 | 2014 | 85 | 0.110 |
Why?
| | Molecular Mimicry | 1 | 2014 | 42 | 0.110 |
Why?
| | Quality Control | 1 | 2015 | 171 | 0.110 |
Why?
| | Melanoma | 2 | 2013 | 772 | 0.110 |
Why?
| | Escherichia coli O157 | 1 | 2014 | 34 | 0.110 |
Why?
| | Solubility | 1 | 2015 | 245 | 0.110 |
Why?
| | Imidazoles | 1 | 2015 | 244 | 0.110 |
Why?
| | Protein Interaction Mapping | 1 | 2014 | 103 | 0.110 |
Why?
| | Uridine Diphosphate Sugars | 1 | 2014 | 2 | 0.110 |
Why?
| | Static Electricity | 1 | 2014 | 113 | 0.110 |
Why?
| | Neoplasm Invasiveness | 2 | 2013 | 509 | 0.110 |
Why?
| | Pyridoxal Phosphate | 1 | 2014 | 24 | 0.110 |
Why?
| | Mutagenesis | 1 | 2014 | 182 | 0.110 |
Why?
| | Ribulosephosphates | 1 | 2013 | 2 | 0.100 |
Why?
| | Isomerases | 1 | 2013 | 8 | 0.100 |
Why?
| | Genetic Complementation Test | 1 | 2013 | 66 | 0.100 |
Why?
| | Lipoproteins | 1 | 2014 | 163 | 0.100 |
Why?
| | Protein Subunits | 1 | 2014 | 232 | 0.100 |
Why?
| | Multienzyme Complexes | 2 | 2004 | 66 | 0.100 |
Why?
| | Arginine | 1 | 2014 | 260 | 0.100 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2016 | 188 | 0.100 |
Why?
| | Recombinant Fusion Proteins | 1 | 2015 | 672 | 0.100 |
Why?
| | Molecular Docking Simulation | 1 | 2012 | 111 | 0.090 |
Why?
| | Protein Kinase Inhibitors | 1 | 2018 | 914 | 0.090 |
Why?
| | Adenosine Triphosphate | 2 | 2005 | 492 | 0.090 |
Why?
| | Structure-Activity Relationship | 1 | 2013 | 579 | 0.090 |
Why?
| | Lipid-Linked Proteins | 1 | 2011 | 1 | 0.090 |
Why?
| | Proteins | 1 | 2017 | 1010 | 0.090 |
Why?
| | Host-Pathogen Interactions | 1 | 2014 | 372 | 0.090 |
Why?
| | Tandem Repeat Sequences | 1 | 2010 | 20 | 0.090 |
Why?
| | Crystallography | 1 | 2010 | 29 | 0.090 |
Why?
| | Blotting, Western | 1 | 2013 | 1234 | 0.080 |
Why?
| | NF-kappa B | 1 | 2014 | 692 | 0.080 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2011 | 614 | 0.080 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2009 | 88 | 0.070 |
Why?
| | Amino Acids | 1 | 2012 | 497 | 0.070 |
Why?
| | Peptides | 1 | 2014 | 978 | 0.070 |
Why?
| | Methionine | 1 | 2009 | 159 | 0.070 |
Why?
| | Photoreceptor Cells | 1 | 2008 | 17 | 0.070 |
Why?
| | Myristic Acids | 1 | 2007 | 8 | 0.070 |
Why?
| | Cell Line, Tumor | 2 | 2013 | 3469 | 0.070 |
Why?
| | Molecular Structure | 2 | 2025 | 503 | 0.070 |
Why?
| | DNA | 1 | 2014 | 1444 | 0.070 |
Why?
| | Humans | 8 | 2023 | 141187 | 0.070 |
Why?
| | Chickens | 1 | 2007 | 189 | 0.070 |
Why?
| | Biomechanical Phenomena | 1 | 2010 | 835 | 0.070 |
Why?
| | Protein Transport | 1 | 2009 | 448 | 0.070 |
Why?
| | Fatty Acids | 1 | 2010 | 448 | 0.060 |
Why?
| | Skin Neoplasms | 1 | 2013 | 849 | 0.060 |
Why?
| | Enzyme Activation | 2 | 2009 | 811 | 0.060 |
Why?
| | Spectrum Analysis, Raman | 1 | 2005 | 43 | 0.060 |
Why?
| | UDPglucose 4-Epimerase | 1 | 2004 | 2 | 0.060 |
Why?
| | Stereoisomerism | 1 | 2025 | 107 | 0.060 |
Why?
| | Molecular Conformation | 1 | 2005 | 147 | 0.060 |
Why?
| | Dimerization | 1 | 2005 | 196 | 0.060 |
Why?
| | Catalysis | 1 | 2005 | 320 | 0.050 |
Why?
| | DNA Primers | 1 | 2005 | 510 | 0.050 |
Why?
| | ATP-Dependent Proteases | 1 | 2002 | 2 | 0.050 |
Why?
| | Cysteine Endopeptidases | 1 | 2002 | 74 | 0.050 |
Why?
| | Allosteric Regulation | 1 | 2002 | 89 | 0.050 |
Why?
| | Endopeptidases | 1 | 2002 | 85 | 0.050 |
Why?
| | Haemophilus influenzae | 1 | 2002 | 63 | 0.050 |
Why?
| | Macromolecular Substances | 1 | 2002 | 226 | 0.040 |
Why?
| | Protease Inhibitors | 1 | 2002 | 105 | 0.040 |
Why?
| | Sulfones | 1 | 2002 | 110 | 0.040 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2003 | 226 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2005 | 1086 | 0.040 |
Why?
| | Adenosine Triphosphatases | 1 | 2002 | 159 | 0.040 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2002 | 161 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2004 | 889 | 0.040 |
Why?
| | Peptide Fragments | 1 | 2004 | 698 | 0.040 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2017 | 19 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2017 | 556 | 0.030 |
Why?
| | Elasticity | 1 | 2016 | 194 | 0.030 |
Why?
| | Biocatalysis | 1 | 2015 | 69 | 0.030 |
Why?
| | Lipase | 1 | 2015 | 68 | 0.030 |
Why?
| | Bacillus subtilis | 1 | 2015 | 66 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2016 | 194 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2015 | 377 | 0.030 |
Why?
| | Temperature | 1 | 2017 | 669 | 0.030 |
Why?
| | Time Factors | 1 | 2004 | 6956 | 0.030 |
Why?
| | Water | 1 | 2016 | 464 | 0.020 |
Why?
| | Animals | 3 | 2009 | 37657 | 0.020 |
Why?
| | Deuterium Exchange Measurement | 1 | 2010 | 27 | 0.020 |
Why?
| | Acylation | 1 | 2010 | 31 | 0.020 |
Why?
| | S-Adenosylmethionine | 1 | 2009 | 56 | 0.020 |
Why?
| | Transplantation, Heterologous | 1 | 2009 | 193 | 0.020 |
Why?
| | Mice, Nude | 1 | 2009 | 691 | 0.020 |
Why?
| | RNA Interference | 1 | 2009 | 469 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2009 | 674 | 0.020 |
Why?
| | Computational Biology | 1 | 2011 | 661 | 0.020 |
Why?
| | Software | 1 | 2011 | 676 | 0.010 |
Why?
| | Eye Proteins | 1 | 2003 | 93 | 0.010 |
Why?
| | Proteomics | 1 | 2009 | 1134 | 0.010 |
Why?
| | Signal Transduction | 1 | 2009 | 5144 | 0.010 |
Why?
| | Mice | 1 | 2009 | 18048 | 0.010 |
Why?
| | Female | 1 | 2009 | 75515 | 0.000 |
Why?
|
|
Sousa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|